Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Supply, Demand and Key Producers, 2026-2032
The global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market size is expected to reach $ 2317 million by 2032, rising at a market growth of 4.7% CAGR during the forecast period (2026-2032).
Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent refers to a complete diagnostic reagent system based on enzyme-linked immunosorbent assay technology for detecting pathogen antigens or antibodies, autoantibodies, hormones, tumor-related markers, and specialty protein biomarkers in human serum, plasma, and other clinical specimens. A typical product generally includes pre-coated microplates, enzyme-labeled antibodies or antigens, calibrators, controls, sample diluents, wash buffers, chromogenic substrates, stop solutions, and related auxiliary components. These reagents are widely used in infectious disease screening, blood safety testing, autoimmune disease diagnostics, endocrine and fertility testing, and selected specialty biomarker assays. Key upstream materials include recombinant antigens, monoclonal and polyclonal antibodies, horseradish peroxidase or alkaline phosphatase conjugates, polystyrene microplates, bovine serum albumin, buffering salts, chromogenic substrates, stabilizers, preservatives, and medical-grade packaging materials. Major downstream customers include hospital clinical laboratories, blood centers and blood screening institutions, third-party medical testing laboratories, public health and disease control agencies, and regional diagnostic reagent distributors. On an ex-factory price basis, the overall gross margin of the global medical ELISA diagnostic reagent industry in 2025 is estimated at approximately 48%?59%. Routine infectious disease screening reagents generally operate at comparatively lower margins due to stronger price competition and procurement pressure, while autoimmune, specialty protein, and niche biomarker ELISA reagents usually achieve better profitability because of higher technical barriers, stronger product differentiation, and greater value per assay.
The medical ELISA diagnostic reagent market has entered a mature stage of development, with demand mainly supported by infectious disease screening, blood safety testing, autoimmune disease diagnostics, endocrine and fertility testing, and selected specialty biomarker applications. Compared with more automated immunoassay platforms, ELISA reagents still retain practical advantages in workflow familiarity, cost accessibility, menu flexibility, and compatibility with established laboratory routines. They remain especially relevant in blood centers, public health laboratories, regional diagnostic facilities, and many emerging markets where fully automated high-end platforms are not always the most economical choice. At the same time, market competition has become increasingly segmented. Routine infectious disease assays are more exposed to procurement pressure and price competition, whereas autoimmune, specialty protein, and disease-monitoring assays are more strongly differentiated by clinical value, analytical performance, and regulatory credibility.
Looking ahead, medical ELISA diagnostic reagents are unlikely to disappear because of the rise of chemiluminescence immunoassays, molecular diagnostics, or rapid testing technologies. Instead, the market is evolving toward a more selective structure in which core demand scenarios are retained, highly commoditized assays face increasing pressure, and specialty applications gain greater strategic importance. Recent industry activity shows that leading companies are still investing in specialty ELISA portfolios, either through asset acquisitions or through the launch of updated serological assays for clinically relevant use cases. This indicates that the segment still offers room for product renewal and targeted expansion. Future competition will increasingly depend on assay specificity, clinical interpretability, reagent stability, lot-to-lot consistency, compatibility with automated or semi-automated workflows, and the ability to secure and maintain multi-regional regulatory approvals.
Several factors continue to support the development of the industry. Ongoing needs in infectious disease surveillance, donor blood safety, autoimmune disease recognition, and specialty diagnostics provide a stable demand foundation. In parallel, established manufacturers are strengthening high-value assay menus to defend profitability and deepen customer relationships. The tightening European regulatory environment is also reshaping competition. More rigorous requirements for conformity assessment, technical documentation, performance evaluation, and post-market oversight raise compliance costs, but they also favor companies with stronger quality systems, regulatory capabilities, and durable product portfolios. For leading suppliers, this creates an opportunity to consolidate positions and shift the market away from fragmented, low-quality competition toward a more standardized and brand-sensitive structure.
The main constraints are equally clear. Routine ELISA assays, especially in infectious disease screening, continue to face substitution pressure from higher-throughput and more automated technologies in large hospital laboratories and centralized testing platforms. Price pressure remains significant in standardized products, while differences in raw material quality, antigen and antibody selection, reagent stability, and national regulatory expectations make global commercialization more complex. Smaller manufacturers without differentiated assays, sustained registration investment, or strong quality systems may find it increasingly difficult to defend their position. Overall, the market will remain relevant and commercially viable, but competitive advantage will be increasingly determined by specialty assay depth, regulatory strength, brand reliability, and refined supply capabilities rather than by simple expansion of conventional product menus.
This report studies the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent total market, 2021-2032, (USD Million)
Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent total market, key domestic companies, and share, (USD Million)
Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent revenue by player, revenue and market share 2021-2026, (USD Million)
Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent total market by Type, CAGR, 2021-2032, (USD Million)
Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad Laboratories, Revvity, Sebia, Tecan Group, BioVendor Group, Trinity Biotech, Dia.Pro Diagnostic Bioprobes, Vircell, SERION Diagnostics, DRG International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market, By Region:
1. How big is the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market?
2. What is the demand of the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market?
3. What is the year over year growth of the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market?
4. What is the total value of the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market?
5. Who are the Major Players in the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market?
6. What are the growth factors driving the market demand?
Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent refers to a complete diagnostic reagent system based on enzyme-linked immunosorbent assay technology for detecting pathogen antigens or antibodies, autoantibodies, hormones, tumor-related markers, and specialty protein biomarkers in human serum, plasma, and other clinical specimens. A typical product generally includes pre-coated microplates, enzyme-labeled antibodies or antigens, calibrators, controls, sample diluents, wash buffers, chromogenic substrates, stop solutions, and related auxiliary components. These reagents are widely used in infectious disease screening, blood safety testing, autoimmune disease diagnostics, endocrine and fertility testing, and selected specialty biomarker assays. Key upstream materials include recombinant antigens, monoclonal and polyclonal antibodies, horseradish peroxidase or alkaline phosphatase conjugates, polystyrene microplates, bovine serum albumin, buffering salts, chromogenic substrates, stabilizers, preservatives, and medical-grade packaging materials. Major downstream customers include hospital clinical laboratories, blood centers and blood screening institutions, third-party medical testing laboratories, public health and disease control agencies, and regional diagnostic reagent distributors. On an ex-factory price basis, the overall gross margin of the global medical ELISA diagnostic reagent industry in 2025 is estimated at approximately 48%?59%. Routine infectious disease screening reagents generally operate at comparatively lower margins due to stronger price competition and procurement pressure, while autoimmune, specialty protein, and niche biomarker ELISA reagents usually achieve better profitability because of higher technical barriers, stronger product differentiation, and greater value per assay.
The medical ELISA diagnostic reagent market has entered a mature stage of development, with demand mainly supported by infectious disease screening, blood safety testing, autoimmune disease diagnostics, endocrine and fertility testing, and selected specialty biomarker applications. Compared with more automated immunoassay platforms, ELISA reagents still retain practical advantages in workflow familiarity, cost accessibility, menu flexibility, and compatibility with established laboratory routines. They remain especially relevant in blood centers, public health laboratories, regional diagnostic facilities, and many emerging markets where fully automated high-end platforms are not always the most economical choice. At the same time, market competition has become increasingly segmented. Routine infectious disease assays are more exposed to procurement pressure and price competition, whereas autoimmune, specialty protein, and disease-monitoring assays are more strongly differentiated by clinical value, analytical performance, and regulatory credibility.
Looking ahead, medical ELISA diagnostic reagents are unlikely to disappear because of the rise of chemiluminescence immunoassays, molecular diagnostics, or rapid testing technologies. Instead, the market is evolving toward a more selective structure in which core demand scenarios are retained, highly commoditized assays face increasing pressure, and specialty applications gain greater strategic importance. Recent industry activity shows that leading companies are still investing in specialty ELISA portfolios, either through asset acquisitions or through the launch of updated serological assays for clinically relevant use cases. This indicates that the segment still offers room for product renewal and targeted expansion. Future competition will increasingly depend on assay specificity, clinical interpretability, reagent stability, lot-to-lot consistency, compatibility with automated or semi-automated workflows, and the ability to secure and maintain multi-regional regulatory approvals.
Several factors continue to support the development of the industry. Ongoing needs in infectious disease surveillance, donor blood safety, autoimmune disease recognition, and specialty diagnostics provide a stable demand foundation. In parallel, established manufacturers are strengthening high-value assay menus to defend profitability and deepen customer relationships. The tightening European regulatory environment is also reshaping competition. More rigorous requirements for conformity assessment, technical documentation, performance evaluation, and post-market oversight raise compliance costs, but they also favor companies with stronger quality systems, regulatory capabilities, and durable product portfolios. For leading suppliers, this creates an opportunity to consolidate positions and shift the market away from fragmented, low-quality competition toward a more standardized and brand-sensitive structure.
The main constraints are equally clear. Routine ELISA assays, especially in infectious disease screening, continue to face substitution pressure from higher-throughput and more automated technologies in large hospital laboratories and centralized testing platforms. Price pressure remains significant in standardized products, while differences in raw material quality, antigen and antibody selection, reagent stability, and national regulatory expectations make global commercialization more complex. Smaller manufacturers without differentiated assays, sustained registration investment, or strong quality systems may find it increasingly difficult to defend their position. Overall, the market will remain relevant and commercially viable, but competitive advantage will be increasingly determined by specialty assay depth, regulatory strength, brand reliability, and refined supply capabilities rather than by simple expansion of conventional product menus.
This report studies the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent total market, 2021-2032, (USD Million)
Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent total market, key domestic companies, and share, (USD Million)
Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent revenue by player, revenue and market share 2021-2026, (USD Million)
Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent total market by Type, CAGR, 2021-2032, (USD Million)
Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad Laboratories, Revvity, Sebia, Tecan Group, BioVendor Group, Trinity Biotech, Dia.Pro Diagnostic Bioprobes, Vircell, SERION Diagnostics, DRG International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Antigen Detection
- Antibody Detection
- Hormone Detection
- Other
- Qualitative Assays
- Semi-quantitative Assays
- Quantitative Assays
- Sandwich ELISA
- Indirect ELISA
- Other
- Hospitals and Clinical Laboratories
- Blood Centers and Plasma Screening Institutions
- Independent Medical Laboratories
- Other
- Bio-Rad Laboratories
- Revvity
- Sebia
- Tecan Group
- BioVendor Group
- Trinity Biotech
- Dia.Pro Diagnostic Bioprobes
- Vircell
- SERION Diagnostics
- DRG International
- Demeditec Diagnostics
- Mediagnost
- AESKU.GROUP
- Monobind
- Diagnostics Biochem Canada
- Epitope Diagnostics
- Beijing Wantai Biological Pharmacy Enterprise
- Shanghai Kehua Bio-engineering
- Livzon Pharmaceutical Group
- Daan Gene
- InTec PRODUCTS
- J. Mitra & Co.
- Meril Life Sciences
- Tulip Diagnostics
- Medical & Biological Laboratories
- GenBody
1. How big is the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market?
2. What is the demand of the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market?
3. What is the year over year growth of the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market?
4. What is the total value of the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market?
5. Who are the Major Players in the global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Introduction
1.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Total Market by Region (by Headquarter Location)
1.3.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.3.3 China Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.3.4 Europe Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.3.5 Japan Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.3.6 South Korea Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.3.7 ASEAN Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.3.8 India Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value by Region
2.2.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value by Region (2021-2026)
2.2.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Forecast by Region (2027-2032)
2.3 United States Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.4 China Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.5 Europe Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.6 Japan Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.7 South Korea Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.8 ASEAN Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.9 India Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
3 WORLD MEDICAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) REAGENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent in 2025
3.2.3 Global Concentration Ratios (CR8) for Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent in 2025
3.3 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Company Evaluation Quadrant
3.4 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market: Overall Company Footprint Analysis
3.4.1 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market: Region Footprint
3.4.2 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market: Company Product Type Footprint
3.4.3 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Comparison
4.2.1 United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies and Market Share, 2021-2026
4.3.1 United States Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, (2021-2026)
4.4 China Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue and Market Share, 2021-2026
4.4.1 China Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, (2021-2026)
4.5 Rest of World Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Antigen Detection
5.2.2 Antibody Detection
5.2.3 Hormone Detection
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Type (2021-2026)
5.3.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Type (2027-2032)
5.3.3 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY ASSAY OUTPUT
6.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Overview by Assay Output: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Assay Output
6.2.1 Qualitative Assays
6.2.2 Semi-quantitative Assays
6.2.3 Quantitative Assays
6.3 Market Segment by Assay Output
6.3.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Output (2021-2026)
6.3.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Output (2027-2032)
6.3.3 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Assay Output (2027-2032)
7 MARKET ANALYSIS BY ASSAY FORMAT
7.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Overview by Assay Format: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Assay Format
7.2.1 Sandwich ELISA
7.2.2 Indirect ELISA
7.2.3 Other
7.3 Market Segment by Assay Format
7.3.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Format (2021-2026)
7.3.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Format (2027-2032)
7.3.3 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Assay Format (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals and Clinical Laboratories
8.2.2 Blood Centers and Plasma Screening Institutions
8.2.3 Independent Medical Laboratories
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Application (2021-2026)
8.3.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Application (2027-2032)
8.3.3 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Bio-Rad Laboratories
9.1.1 Bio-Rad Laboratories Details
9.1.2 Bio-Rad Laboratories Major Business
9.1.3 Bio-Rad Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.1.4 Bio-Rad Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Bio-Rad Laboratories Recent Developments/Updates
9.1.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
9.2 Revvity
9.2.1 Revvity Details
9.2.2 Revvity Major Business
9.2.3 Revvity Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.2.4 Revvity Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Revvity Recent Developments/Updates
9.2.6 Revvity Competitive Strengths & Weaknesses
9.3 Sebia
9.3.1 Sebia Details
9.3.2 Sebia Major Business
9.3.3 Sebia Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.3.4 Sebia Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Sebia Recent Developments/Updates
9.3.6 Sebia Competitive Strengths & Weaknesses
9.4 Tecan Group
9.4.1 Tecan Group Details
9.4.2 Tecan Group Major Business
9.4.3 Tecan Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.4.4 Tecan Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Tecan Group Recent Developments/Updates
9.4.6 Tecan Group Competitive Strengths & Weaknesses
9.5 BioVendor Group
9.5.1 BioVendor Group Details
9.5.2 BioVendor Group Major Business
9.5.3 BioVendor Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.5.4 BioVendor Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 BioVendor Group Recent Developments/Updates
9.5.6 BioVendor Group Competitive Strengths & Weaknesses
9.6 Trinity Biotech
9.6.1 Trinity Biotech Details
9.6.2 Trinity Biotech Major Business
9.6.3 Trinity Biotech Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.6.4 Trinity Biotech Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Trinity Biotech Recent Developments/Updates
9.6.6 Trinity Biotech Competitive Strengths & Weaknesses
9.7 Dia.Pro Diagnostic Bioprobes
9.7.1 Dia.Pro Diagnostic Bioprobes Details
9.7.2 Dia.Pro Diagnostic Bioprobes Major Business
9.7.3 Dia.Pro Diagnostic Bioprobes Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.7.4 Dia.Pro Diagnostic Bioprobes Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Dia.Pro Diagnostic Bioprobes Recent Developments/Updates
9.7.6 Dia.Pro Diagnostic Bioprobes Competitive Strengths & Weaknesses
9.8 Vircell
9.8.1 Vircell Details
9.8.2 Vircell Major Business
9.8.3 Vircell Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.8.4 Vircell Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Vircell Recent Developments/Updates
9.8.6 Vircell Competitive Strengths & Weaknesses
9.9 SERION Diagnostics
9.9.1 SERION Diagnostics Details
9.9.2 SERION Diagnostics Major Business
9.9.3 SERION Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.9.4 SERION Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 SERION Diagnostics Recent Developments/Updates
9.9.6 SERION Diagnostics Competitive Strengths & Weaknesses
9.10 DRG International
9.10.1 DRG International Details
9.10.2 DRG International Major Business
9.10.3 DRG International Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.10.4 DRG International Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 DRG International Recent Developments/Updates
9.10.6 DRG International Competitive Strengths & Weaknesses
9.11 Demeditec Diagnostics
9.11.1 Demeditec Diagnostics Details
9.11.2 Demeditec Diagnostics Major Business
9.11.3 Demeditec Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.11.4 Demeditec Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Demeditec Diagnostics Recent Developments/Updates
9.11.6 Demeditec Diagnostics Competitive Strengths & Weaknesses
9.12 Mediagnost
9.12.1 Mediagnost Details
9.12.2 Mediagnost Major Business
9.12.3 Mediagnost Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.12.4 Mediagnost Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Mediagnost Recent Developments/Updates
9.12.6 Mediagnost Competitive Strengths & Weaknesses
9.13 AESKU.GROUP
9.13.1 AESKU.GROUP Details
9.13.2 AESKU.GROUP Major Business
9.13.3 AESKU.GROUP Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.13.4 AESKU.GROUP Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 AESKU.GROUP Recent Developments/Updates
9.13.6 AESKU.GROUP Competitive Strengths & Weaknesses
9.14 Monobind
9.14.1 Monobind Details
9.14.2 Monobind Major Business
9.14.3 Monobind Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.14.4 Monobind Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Monobind Recent Developments/Updates
9.14.6 Monobind Competitive Strengths & Weaknesses
9.15 Diagnostics Biochem Canada
9.15.1 Diagnostics Biochem Canada Details
9.15.2 Diagnostics Biochem Canada Major Business
9.15.3 Diagnostics Biochem Canada Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.15.4 Diagnostics Biochem Canada Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Diagnostics Biochem Canada Recent Developments/Updates
9.15.6 Diagnostics Biochem Canada Competitive Strengths & Weaknesses
9.16 Epitope Diagnostics
9.16.1 Epitope Diagnostics Details
9.16.2 Epitope Diagnostics Major Business
9.16.3 Epitope Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.16.4 Epitope Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Epitope Diagnostics Recent Developments/Updates
9.16.6 Epitope Diagnostics Competitive Strengths & Weaknesses
9.17 Beijing Wantai Biological Pharmacy Enterprise
9.17.1 Beijing Wantai Biological Pharmacy Enterprise Details
9.17.2 Beijing Wantai Biological Pharmacy Enterprise Major Business
9.17.3 Beijing Wantai Biological Pharmacy Enterprise Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.17.4 Beijing Wantai Biological Pharmacy Enterprise Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
9.17.6 Beijing Wantai Biological Pharmacy Enterprise Competitive Strengths & Weaknesses
9.18 Shanghai Kehua Bio-engineering
9.18.1 Shanghai Kehua Bio-engineering Details
9.18.2 Shanghai Kehua Bio-engineering Major Business
9.18.3 Shanghai Kehua Bio-engineering Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.18.4 Shanghai Kehua Bio-engineering Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Shanghai Kehua Bio-engineering Recent Developments/Updates
9.18.6 Shanghai Kehua Bio-engineering Competitive Strengths & Weaknesses
9.19 Livzon Pharmaceutical Group
9.19.1 Livzon Pharmaceutical Group Details
9.19.2 Livzon Pharmaceutical Group Major Business
9.19.3 Livzon Pharmaceutical Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.19.4 Livzon Pharmaceutical Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Livzon Pharmaceutical Group Recent Developments/Updates
9.19.6 Livzon Pharmaceutical Group Competitive Strengths & Weaknesses
9.20 Daan Gene
9.20.1 Daan Gene Details
9.20.2 Daan Gene Major Business
9.20.3 Daan Gene Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.20.4 Daan Gene Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Daan Gene Recent Developments/Updates
9.20.6 Daan Gene Competitive Strengths & Weaknesses
9.21 InTec PRODUCTS
9.21.1 InTec PRODUCTS Details
9.21.2 InTec PRODUCTS Major Business
9.21.3 InTec PRODUCTS Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.21.4 InTec PRODUCTS Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 InTec PRODUCTS Recent Developments/Updates
9.21.6 InTec PRODUCTS Competitive Strengths & Weaknesses
9.22 J. Mitra & Co.
9.22.1 J. Mitra & Co. Details
9.22.2 J. Mitra & Co. Major Business
9.22.3 J. Mitra & Co. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.22.4 J. Mitra & Co. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 J. Mitra & Co. Recent Developments/Updates
9.22.6 J. Mitra & Co. Competitive Strengths & Weaknesses
9.23 Meril Life Sciences
9.23.1 Meril Life Sciences Details
9.23.2 Meril Life Sciences Major Business
9.23.3 Meril Life Sciences Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.23.4 Meril Life Sciences Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Meril Life Sciences Recent Developments/Updates
9.23.6 Meril Life Sciences Competitive Strengths & Weaknesses
9.24 Tulip Diagnostics
9.24.1 Tulip Diagnostics Details
9.24.2 Tulip Diagnostics Major Business
9.24.3 Tulip Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.24.4 Tulip Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Tulip Diagnostics Recent Developments/Updates
9.24.6 Tulip Diagnostics Competitive Strengths & Weaknesses
9.25 Medical & Biological Laboratories
9.25.1 Medical & Biological Laboratories Details
9.25.2 Medical & Biological Laboratories Major Business
9.25.3 Medical & Biological Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.25.4 Medical & Biological Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Medical & Biological Laboratories Recent Developments/Updates
9.25.6 Medical & Biological Laboratories Competitive Strengths & Weaknesses
9.26 GenBody
9.26.1 GenBody Details
9.26.2 GenBody Major Business
9.26.3 GenBody Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.26.4 GenBody Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 GenBody Recent Developments/Updates
9.26.6 GenBody Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Industry Chain
10.2 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Upstream Analysis
10.3 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Midstream Analysis
10.4 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Introduction
1.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Total Market by Region (by Headquarter Location)
1.3.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.3.3 China Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.3.4 Europe Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.3.5 Japan Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.3.6 South Korea Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.3.7 ASEAN Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.3.8 India Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value by Region
2.2.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value by Region (2021-2026)
2.2.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Forecast by Region (2027-2032)
2.3 United States Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.4 China Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.5 Europe Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.6 Japan Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.7 South Korea Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.8 ASEAN Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
2.9 India Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032)
3 WORLD MEDICAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) REAGENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent in 2025
3.2.3 Global Concentration Ratios (CR8) for Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent in 2025
3.3 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Company Evaluation Quadrant
3.4 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market: Overall Company Footprint Analysis
3.4.1 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market: Region Footprint
3.4.2 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market: Company Product Type Footprint
3.4.3 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Comparison
4.2.1 United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies and Market Share, 2021-2026
4.3.1 United States Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, (2021-2026)
4.4 China Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue and Market Share, 2021-2026
4.4.1 China Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, (2021-2026)
4.5 Rest of World Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Antigen Detection
5.2.2 Antibody Detection
5.2.3 Hormone Detection
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Type (2021-2026)
5.3.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Type (2027-2032)
5.3.3 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY ASSAY OUTPUT
6.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Overview by Assay Output: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Assay Output
6.2.1 Qualitative Assays
6.2.2 Semi-quantitative Assays
6.2.3 Quantitative Assays
6.3 Market Segment by Assay Output
6.3.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Output (2021-2026)
6.3.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Output (2027-2032)
6.3.3 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Assay Output (2027-2032)
7 MARKET ANALYSIS BY ASSAY FORMAT
7.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Overview by Assay Format: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Assay Format
7.2.1 Sandwich ELISA
7.2.2 Indirect ELISA
7.2.3 Other
7.3 Market Segment by Assay Format
7.3.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Format (2021-2026)
7.3.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Format (2027-2032)
7.3.3 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Assay Format (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals and Clinical Laboratories
8.2.2 Blood Centers and Plasma Screening Institutions
8.2.3 Independent Medical Laboratories
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Application (2021-2026)
8.3.2 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Application (2027-2032)
8.3.3 World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Bio-Rad Laboratories
9.1.1 Bio-Rad Laboratories Details
9.1.2 Bio-Rad Laboratories Major Business
9.1.3 Bio-Rad Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.1.4 Bio-Rad Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Bio-Rad Laboratories Recent Developments/Updates
9.1.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
9.2 Revvity
9.2.1 Revvity Details
9.2.2 Revvity Major Business
9.2.3 Revvity Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.2.4 Revvity Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Revvity Recent Developments/Updates
9.2.6 Revvity Competitive Strengths & Weaknesses
9.3 Sebia
9.3.1 Sebia Details
9.3.2 Sebia Major Business
9.3.3 Sebia Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.3.4 Sebia Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Sebia Recent Developments/Updates
9.3.6 Sebia Competitive Strengths & Weaknesses
9.4 Tecan Group
9.4.1 Tecan Group Details
9.4.2 Tecan Group Major Business
9.4.3 Tecan Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.4.4 Tecan Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Tecan Group Recent Developments/Updates
9.4.6 Tecan Group Competitive Strengths & Weaknesses
9.5 BioVendor Group
9.5.1 BioVendor Group Details
9.5.2 BioVendor Group Major Business
9.5.3 BioVendor Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.5.4 BioVendor Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 BioVendor Group Recent Developments/Updates
9.5.6 BioVendor Group Competitive Strengths & Weaknesses
9.6 Trinity Biotech
9.6.1 Trinity Biotech Details
9.6.2 Trinity Biotech Major Business
9.6.3 Trinity Biotech Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.6.4 Trinity Biotech Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Trinity Biotech Recent Developments/Updates
9.6.6 Trinity Biotech Competitive Strengths & Weaknesses
9.7 Dia.Pro Diagnostic Bioprobes
9.7.1 Dia.Pro Diagnostic Bioprobes Details
9.7.2 Dia.Pro Diagnostic Bioprobes Major Business
9.7.3 Dia.Pro Diagnostic Bioprobes Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.7.4 Dia.Pro Diagnostic Bioprobes Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Dia.Pro Diagnostic Bioprobes Recent Developments/Updates
9.7.6 Dia.Pro Diagnostic Bioprobes Competitive Strengths & Weaknesses
9.8 Vircell
9.8.1 Vircell Details
9.8.2 Vircell Major Business
9.8.3 Vircell Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.8.4 Vircell Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Vircell Recent Developments/Updates
9.8.6 Vircell Competitive Strengths & Weaknesses
9.9 SERION Diagnostics
9.9.1 SERION Diagnostics Details
9.9.2 SERION Diagnostics Major Business
9.9.3 SERION Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.9.4 SERION Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 SERION Diagnostics Recent Developments/Updates
9.9.6 SERION Diagnostics Competitive Strengths & Weaknesses
9.10 DRG International
9.10.1 DRG International Details
9.10.2 DRG International Major Business
9.10.3 DRG International Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.10.4 DRG International Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 DRG International Recent Developments/Updates
9.10.6 DRG International Competitive Strengths & Weaknesses
9.11 Demeditec Diagnostics
9.11.1 Demeditec Diagnostics Details
9.11.2 Demeditec Diagnostics Major Business
9.11.3 Demeditec Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.11.4 Demeditec Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Demeditec Diagnostics Recent Developments/Updates
9.11.6 Demeditec Diagnostics Competitive Strengths & Weaknesses
9.12 Mediagnost
9.12.1 Mediagnost Details
9.12.2 Mediagnost Major Business
9.12.3 Mediagnost Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.12.4 Mediagnost Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Mediagnost Recent Developments/Updates
9.12.6 Mediagnost Competitive Strengths & Weaknesses
9.13 AESKU.GROUP
9.13.1 AESKU.GROUP Details
9.13.2 AESKU.GROUP Major Business
9.13.3 AESKU.GROUP Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.13.4 AESKU.GROUP Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 AESKU.GROUP Recent Developments/Updates
9.13.6 AESKU.GROUP Competitive Strengths & Weaknesses
9.14 Monobind
9.14.1 Monobind Details
9.14.2 Monobind Major Business
9.14.3 Monobind Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.14.4 Monobind Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Monobind Recent Developments/Updates
9.14.6 Monobind Competitive Strengths & Weaknesses
9.15 Diagnostics Biochem Canada
9.15.1 Diagnostics Biochem Canada Details
9.15.2 Diagnostics Biochem Canada Major Business
9.15.3 Diagnostics Biochem Canada Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.15.4 Diagnostics Biochem Canada Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Diagnostics Biochem Canada Recent Developments/Updates
9.15.6 Diagnostics Biochem Canada Competitive Strengths & Weaknesses
9.16 Epitope Diagnostics
9.16.1 Epitope Diagnostics Details
9.16.2 Epitope Diagnostics Major Business
9.16.3 Epitope Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.16.4 Epitope Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Epitope Diagnostics Recent Developments/Updates
9.16.6 Epitope Diagnostics Competitive Strengths & Weaknesses
9.17 Beijing Wantai Biological Pharmacy Enterprise
9.17.1 Beijing Wantai Biological Pharmacy Enterprise Details
9.17.2 Beijing Wantai Biological Pharmacy Enterprise Major Business
9.17.3 Beijing Wantai Biological Pharmacy Enterprise Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.17.4 Beijing Wantai Biological Pharmacy Enterprise Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
9.17.6 Beijing Wantai Biological Pharmacy Enterprise Competitive Strengths & Weaknesses
9.18 Shanghai Kehua Bio-engineering
9.18.1 Shanghai Kehua Bio-engineering Details
9.18.2 Shanghai Kehua Bio-engineering Major Business
9.18.3 Shanghai Kehua Bio-engineering Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.18.4 Shanghai Kehua Bio-engineering Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Shanghai Kehua Bio-engineering Recent Developments/Updates
9.18.6 Shanghai Kehua Bio-engineering Competitive Strengths & Weaknesses
9.19 Livzon Pharmaceutical Group
9.19.1 Livzon Pharmaceutical Group Details
9.19.2 Livzon Pharmaceutical Group Major Business
9.19.3 Livzon Pharmaceutical Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.19.4 Livzon Pharmaceutical Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Livzon Pharmaceutical Group Recent Developments/Updates
9.19.6 Livzon Pharmaceutical Group Competitive Strengths & Weaknesses
9.20 Daan Gene
9.20.1 Daan Gene Details
9.20.2 Daan Gene Major Business
9.20.3 Daan Gene Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.20.4 Daan Gene Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Daan Gene Recent Developments/Updates
9.20.6 Daan Gene Competitive Strengths & Weaknesses
9.21 InTec PRODUCTS
9.21.1 InTec PRODUCTS Details
9.21.2 InTec PRODUCTS Major Business
9.21.3 InTec PRODUCTS Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.21.4 InTec PRODUCTS Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 InTec PRODUCTS Recent Developments/Updates
9.21.6 InTec PRODUCTS Competitive Strengths & Weaknesses
9.22 J. Mitra & Co.
9.22.1 J. Mitra & Co. Details
9.22.2 J. Mitra & Co. Major Business
9.22.3 J. Mitra & Co. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.22.4 J. Mitra & Co. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 J. Mitra & Co. Recent Developments/Updates
9.22.6 J. Mitra & Co. Competitive Strengths & Weaknesses
9.23 Meril Life Sciences
9.23.1 Meril Life Sciences Details
9.23.2 Meril Life Sciences Major Business
9.23.3 Meril Life Sciences Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.23.4 Meril Life Sciences Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Meril Life Sciences Recent Developments/Updates
9.23.6 Meril Life Sciences Competitive Strengths & Weaknesses
9.24 Tulip Diagnostics
9.24.1 Tulip Diagnostics Details
9.24.2 Tulip Diagnostics Major Business
9.24.3 Tulip Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.24.4 Tulip Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Tulip Diagnostics Recent Developments/Updates
9.24.6 Tulip Diagnostics Competitive Strengths & Weaknesses
9.25 Medical & Biological Laboratories
9.25.1 Medical & Biological Laboratories Details
9.25.2 Medical & Biological Laboratories Major Business
9.25.3 Medical & Biological Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.25.4 Medical & Biological Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Medical & Biological Laboratories Recent Developments/Updates
9.25.6 Medical & Biological Laboratories Competitive Strengths & Weaknesses
9.26 GenBody
9.26.1 GenBody Details
9.26.2 GenBody Major Business
9.26.3 GenBody Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
9.26.4 GenBody Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 GenBody Recent Developments/Updates
9.26.6 GenBody Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Industry Chain
10.2 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Upstream Analysis
10.3 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Midstream Analysis
10.4 Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Players in 2025
Table 12. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Company Evaluation Quadrant
Table 14. Head Office of Key Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Players
Table 15. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market: Company Product Type Footprint
Table 16. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market: Company Product Application Footprint
Table 17. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Mergers & Acquisitions Activity
Table 18. United States VS China Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies, Headquarters (States, Country)
Table 21. United States Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share (2021-2026)
Table 23. China Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies, Headquarters (Province, Country)
Table 24. China Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share (2021-2026)
Table 26. Rest of World Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share (2021-2026)
Table 29. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Type (2027-2032) & (USD Million)
Table 32. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Output, (USD Million), 2021 & 2025 & 2032
Table 33. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Value by Assay Output (2021-2026) & (USD Million)
Table 34. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Output (2027-2032) & (USD Million)
Table 35. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Format, (USD Million), 2021 & 2025 & 2032
Table 36. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Value by Assay Format (2021-2026) & (USD Million)
Table 37. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Format (2027-2032) & (USD Million)
Table 38. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Application (2021-2026) & (USD Million)
Table 40. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Application (2027-2032) & (USD Million)
Table 41. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 42. Bio-Rad Laboratories Major Business
Table 43. Bio-Rad Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 44. Bio-Rad Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Bio-Rad Laboratories Recent Developments/Updates
Table 46. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 47. Revvity Basic Information, Manufacturing Base and Competitors
Table 48. Revvity Major Business
Table 49. Revvity Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 50. Revvity Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Revvity Recent Developments/Updates
Table 52. Revvity Competitive Strengths & Weaknesses
Table 53. Sebia Basic Information, Manufacturing Base and Competitors
Table 54. Sebia Major Business
Table 55. Sebia Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 56. Sebia Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sebia Recent Developments/Updates
Table 58. Sebia Competitive Strengths & Weaknesses
Table 59. Tecan Group Basic Information, Manufacturing Base and Competitors
Table 60. Tecan Group Major Business
Table 61. Tecan Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 62. Tecan Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Tecan Group Recent Developments/Updates
Table 64. Tecan Group Competitive Strengths & Weaknesses
Table 65. BioVendor Group Basic Information, Manufacturing Base and Competitors
Table 66. BioVendor Group Major Business
Table 67. BioVendor Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 68. BioVendor Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. BioVendor Group Recent Developments/Updates
Table 70. BioVendor Group Competitive Strengths & Weaknesses
Table 71. Trinity Biotech Basic Information, Manufacturing Base and Competitors
Table 72. Trinity Biotech Major Business
Table 73. Trinity Biotech Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 74. Trinity Biotech Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Trinity Biotech Recent Developments/Updates
Table 76. Trinity Biotech Competitive Strengths & Weaknesses
Table 77. Dia.Pro Diagnostic Bioprobes Basic Information, Manufacturing Base and Competitors
Table 78. Dia.Pro Diagnostic Bioprobes Major Business
Table 79. Dia.Pro Diagnostic Bioprobes Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 80. Dia.Pro Diagnostic Bioprobes Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Dia.Pro Diagnostic Bioprobes Recent Developments/Updates
Table 82. Dia.Pro Diagnostic Bioprobes Competitive Strengths & Weaknesses
Table 83. Vircell Basic Information, Manufacturing Base and Competitors
Table 84. Vircell Major Business
Table 85. Vircell Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 86. Vircell Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Vircell Recent Developments/Updates
Table 88. Vircell Competitive Strengths & Weaknesses
Table 89. SERION Diagnostics Basic Information, Manufacturing Base and Competitors
Table 90. SERION Diagnostics Major Business
Table 91. SERION Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 92. SERION Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. SERION Diagnostics Recent Developments/Updates
Table 94. SERION Diagnostics Competitive Strengths & Weaknesses
Table 95. DRG International Basic Information, Manufacturing Base and Competitors
Table 96. DRG International Major Business
Table 97. DRG International Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 98. DRG International Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. DRG International Recent Developments/Updates
Table 100. DRG International Competitive Strengths & Weaknesses
Table 101. Demeditec Diagnostics Basic Information, Manufacturing Base and Competitors
Table 102. Demeditec Diagnostics Major Business
Table 103. Demeditec Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 104. Demeditec Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Demeditec Diagnostics Recent Developments/Updates
Table 106. Demeditec Diagnostics Competitive Strengths & Weaknesses
Table 107. Mediagnost Basic Information, Manufacturing Base and Competitors
Table 108. Mediagnost Major Business
Table 109. Mediagnost Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 110. Mediagnost Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Mediagnost Recent Developments/Updates
Table 112. Mediagnost Competitive Strengths & Weaknesses
Table 113. AESKU.GROUP Basic Information, Manufacturing Base and Competitors
Table 114. AESKU.GROUP Major Business
Table 115. AESKU.GROUP Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 116. AESKU.GROUP Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. AESKU.GROUP Recent Developments/Updates
Table 118. AESKU.GROUP Competitive Strengths & Weaknesses
Table 119. Monobind Basic Information, Manufacturing Base and Competitors
Table 120. Monobind Major Business
Table 121. Monobind Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 122. Monobind Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Monobind Recent Developments/Updates
Table 124. Monobind Competitive Strengths & Weaknesses
Table 125. Diagnostics Biochem Canada Basic Information, Manufacturing Base and Competitors
Table 126. Diagnostics Biochem Canada Major Business
Table 127. Diagnostics Biochem Canada Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 128. Diagnostics Biochem Canada Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Diagnostics Biochem Canada Recent Developments/Updates
Table 130. Diagnostics Biochem Canada Competitive Strengths & Weaknesses
Table 131. Epitope Diagnostics Basic Information, Manufacturing Base and Competitors
Table 132. Epitope Diagnostics Major Business
Table 133. Epitope Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 134. Epitope Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Epitope Diagnostics Recent Developments/Updates
Table 136. Epitope Diagnostics Competitive Strengths & Weaknesses
Table 137. Beijing Wantai Biological Pharmacy Enterprise Basic Information, Manufacturing Base and Competitors
Table 138. Beijing Wantai Biological Pharmacy Enterprise Major Business
Table 139. Beijing Wantai Biological Pharmacy Enterprise Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 140. Beijing Wantai Biological Pharmacy Enterprise Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
Table 142. Beijing Wantai Biological Pharmacy Enterprise Competitive Strengths & Weaknesses
Table 143. Shanghai Kehua Bio-engineering Basic Information, Manufacturing Base and Competitors
Table 144. Shanghai Kehua Bio-engineering Major Business
Table 145. Shanghai Kehua Bio-engineering Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 146. Shanghai Kehua Bio-engineering Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Shanghai Kehua Bio-engineering Recent Developments/Updates
Table 148. Shanghai Kehua Bio-engineering Competitive Strengths & Weaknesses
Table 149. Livzon Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 150. Livzon Pharmaceutical Group Major Business
Table 151. Livzon Pharmaceutical Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 152. Livzon Pharmaceutical Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Livzon Pharmaceutical Group Recent Developments/Updates
Table 154. Livzon Pharmaceutical Group Competitive Strengths & Weaknesses
Table 155. Daan Gene Basic Information, Manufacturing Base and Competitors
Table 156. Daan Gene Major Business
Table 157. Daan Gene Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 158. Daan Gene Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Daan Gene Recent Developments/Updates
Table 160. Daan Gene Competitive Strengths & Weaknesses
Table 161. InTec PRODUCTS Basic Information, Manufacturing Base and Competitors
Table 162. InTec PRODUCTS Major Business
Table 163. InTec PRODUCTS Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 164. InTec PRODUCTS Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. InTec PRODUCTS Recent Developments/Updates
Table 166. InTec PRODUCTS Competitive Strengths & Weaknesses
Table 167. J. Mitra & Co. Basic Information, Manufacturing Base and Competitors
Table 168. J. Mitra & Co. Major Business
Table 169. J. Mitra & Co. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 170. J. Mitra & Co. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. J. Mitra & Co. Recent Developments/Updates
Table 172. J. Mitra & Co. Competitive Strengths & Weaknesses
Table 173. Meril Life Sciences Basic Information, Manufacturing Base and Competitors
Table 174. Meril Life Sciences Major Business
Table 175. Meril Life Sciences Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 176. Meril Life Sciences Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Meril Life Sciences Recent Developments/Updates
Table 178. Meril Life Sciences Competitive Strengths & Weaknesses
Table 179. Tulip Diagnostics Basic Information, Manufacturing Base and Competitors
Table 180. Tulip Diagnostics Major Business
Table 181. Tulip Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 182. Tulip Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Tulip Diagnostics Recent Developments/Updates
Table 184. Tulip Diagnostics Competitive Strengths & Weaknesses
Table 185. Medical & Biological Laboratories Basic Information, Manufacturing Base and Competitors
Table 186. Medical & Biological Laboratories Major Business
Table 187. Medical & Biological Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 188. Medical & Biological Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Medical & Biological Laboratories Recent Developments/Updates
Table 190. Medical & Biological Laboratories Competitive Strengths & Weaknesses
Table 191. GenBody Basic Information, Manufacturing Base and Competitors
Table 192. GenBody Major Business
Table 193. GenBody Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 194. GenBody Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. GenBody Recent Developments/Updates
Table 196. GenBody Competitive Strengths & Weaknesses
Table 197. Global Key Players of Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Upstream (Raw Materials)
Table 198. Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Typical Customers
Table 1. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Players in 2025
Table 12. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Company Evaluation Quadrant
Table 14. Head Office of Key Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Players
Table 15. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market: Company Product Type Footprint
Table 16. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market: Company Product Application Footprint
Table 17. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Mergers & Acquisitions Activity
Table 18. United States VS China Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies, Headquarters (States, Country)
Table 21. United States Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share (2021-2026)
Table 23. China Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies, Headquarters (Province, Country)
Table 24. China Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share (2021-2026)
Table 26. Rest of World Based Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share (2021-2026)
Table 29. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Type (2027-2032) & (USD Million)
Table 32. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Output, (USD Million), 2021 & 2025 & 2032
Table 33. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Value by Assay Output (2021-2026) & (USD Million)
Table 34. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Output (2027-2032) & (USD Million)
Table 35. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Format, (USD Million), 2021 & 2025 & 2032
Table 36. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Value by Assay Format (2021-2026) & (USD Million)
Table 37. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Format (2027-2032) & (USD Million)
Table 38. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Application (2021-2026) & (USD Million)
Table 40. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Application (2027-2032) & (USD Million)
Table 41. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 42. Bio-Rad Laboratories Major Business
Table 43. Bio-Rad Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 44. Bio-Rad Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Bio-Rad Laboratories Recent Developments/Updates
Table 46. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 47. Revvity Basic Information, Manufacturing Base and Competitors
Table 48. Revvity Major Business
Table 49. Revvity Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 50. Revvity Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Revvity Recent Developments/Updates
Table 52. Revvity Competitive Strengths & Weaknesses
Table 53. Sebia Basic Information, Manufacturing Base and Competitors
Table 54. Sebia Major Business
Table 55. Sebia Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 56. Sebia Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sebia Recent Developments/Updates
Table 58. Sebia Competitive Strengths & Weaknesses
Table 59. Tecan Group Basic Information, Manufacturing Base and Competitors
Table 60. Tecan Group Major Business
Table 61. Tecan Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 62. Tecan Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Tecan Group Recent Developments/Updates
Table 64. Tecan Group Competitive Strengths & Weaknesses
Table 65. BioVendor Group Basic Information, Manufacturing Base and Competitors
Table 66. BioVendor Group Major Business
Table 67. BioVendor Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 68. BioVendor Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. BioVendor Group Recent Developments/Updates
Table 70. BioVendor Group Competitive Strengths & Weaknesses
Table 71. Trinity Biotech Basic Information, Manufacturing Base and Competitors
Table 72. Trinity Biotech Major Business
Table 73. Trinity Biotech Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 74. Trinity Biotech Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Trinity Biotech Recent Developments/Updates
Table 76. Trinity Biotech Competitive Strengths & Weaknesses
Table 77. Dia.Pro Diagnostic Bioprobes Basic Information, Manufacturing Base and Competitors
Table 78. Dia.Pro Diagnostic Bioprobes Major Business
Table 79. Dia.Pro Diagnostic Bioprobes Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 80. Dia.Pro Diagnostic Bioprobes Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Dia.Pro Diagnostic Bioprobes Recent Developments/Updates
Table 82. Dia.Pro Diagnostic Bioprobes Competitive Strengths & Weaknesses
Table 83. Vircell Basic Information, Manufacturing Base and Competitors
Table 84. Vircell Major Business
Table 85. Vircell Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 86. Vircell Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Vircell Recent Developments/Updates
Table 88. Vircell Competitive Strengths & Weaknesses
Table 89. SERION Diagnostics Basic Information, Manufacturing Base and Competitors
Table 90. SERION Diagnostics Major Business
Table 91. SERION Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 92. SERION Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. SERION Diagnostics Recent Developments/Updates
Table 94. SERION Diagnostics Competitive Strengths & Weaknesses
Table 95. DRG International Basic Information, Manufacturing Base and Competitors
Table 96. DRG International Major Business
Table 97. DRG International Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 98. DRG International Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. DRG International Recent Developments/Updates
Table 100. DRG International Competitive Strengths & Weaknesses
Table 101. Demeditec Diagnostics Basic Information, Manufacturing Base and Competitors
Table 102. Demeditec Diagnostics Major Business
Table 103. Demeditec Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 104. Demeditec Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Demeditec Diagnostics Recent Developments/Updates
Table 106. Demeditec Diagnostics Competitive Strengths & Weaknesses
Table 107. Mediagnost Basic Information, Manufacturing Base and Competitors
Table 108. Mediagnost Major Business
Table 109. Mediagnost Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 110. Mediagnost Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Mediagnost Recent Developments/Updates
Table 112. Mediagnost Competitive Strengths & Weaknesses
Table 113. AESKU.GROUP Basic Information, Manufacturing Base and Competitors
Table 114. AESKU.GROUP Major Business
Table 115. AESKU.GROUP Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 116. AESKU.GROUP Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. AESKU.GROUP Recent Developments/Updates
Table 118. AESKU.GROUP Competitive Strengths & Weaknesses
Table 119. Monobind Basic Information, Manufacturing Base and Competitors
Table 120. Monobind Major Business
Table 121. Monobind Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 122. Monobind Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Monobind Recent Developments/Updates
Table 124. Monobind Competitive Strengths & Weaknesses
Table 125. Diagnostics Biochem Canada Basic Information, Manufacturing Base and Competitors
Table 126. Diagnostics Biochem Canada Major Business
Table 127. Diagnostics Biochem Canada Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 128. Diagnostics Biochem Canada Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Diagnostics Biochem Canada Recent Developments/Updates
Table 130. Diagnostics Biochem Canada Competitive Strengths & Weaknesses
Table 131. Epitope Diagnostics Basic Information, Manufacturing Base and Competitors
Table 132. Epitope Diagnostics Major Business
Table 133. Epitope Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 134. Epitope Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Epitope Diagnostics Recent Developments/Updates
Table 136. Epitope Diagnostics Competitive Strengths & Weaknesses
Table 137. Beijing Wantai Biological Pharmacy Enterprise Basic Information, Manufacturing Base and Competitors
Table 138. Beijing Wantai Biological Pharmacy Enterprise Major Business
Table 139. Beijing Wantai Biological Pharmacy Enterprise Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 140. Beijing Wantai Biological Pharmacy Enterprise Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
Table 142. Beijing Wantai Biological Pharmacy Enterprise Competitive Strengths & Weaknesses
Table 143. Shanghai Kehua Bio-engineering Basic Information, Manufacturing Base and Competitors
Table 144. Shanghai Kehua Bio-engineering Major Business
Table 145. Shanghai Kehua Bio-engineering Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 146. Shanghai Kehua Bio-engineering Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Shanghai Kehua Bio-engineering Recent Developments/Updates
Table 148. Shanghai Kehua Bio-engineering Competitive Strengths & Weaknesses
Table 149. Livzon Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 150. Livzon Pharmaceutical Group Major Business
Table 151. Livzon Pharmaceutical Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 152. Livzon Pharmaceutical Group Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Livzon Pharmaceutical Group Recent Developments/Updates
Table 154. Livzon Pharmaceutical Group Competitive Strengths & Weaknesses
Table 155. Daan Gene Basic Information, Manufacturing Base and Competitors
Table 156. Daan Gene Major Business
Table 157. Daan Gene Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 158. Daan Gene Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Daan Gene Recent Developments/Updates
Table 160. Daan Gene Competitive Strengths & Weaknesses
Table 161. InTec PRODUCTS Basic Information, Manufacturing Base and Competitors
Table 162. InTec PRODUCTS Major Business
Table 163. InTec PRODUCTS Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 164. InTec PRODUCTS Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. InTec PRODUCTS Recent Developments/Updates
Table 166. InTec PRODUCTS Competitive Strengths & Weaknesses
Table 167. J. Mitra & Co. Basic Information, Manufacturing Base and Competitors
Table 168. J. Mitra & Co. Major Business
Table 169. J. Mitra & Co. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 170. J. Mitra & Co. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. J. Mitra & Co. Recent Developments/Updates
Table 172. J. Mitra & Co. Competitive Strengths & Weaknesses
Table 173. Meril Life Sciences Basic Information, Manufacturing Base and Competitors
Table 174. Meril Life Sciences Major Business
Table 175. Meril Life Sciences Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 176. Meril Life Sciences Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Meril Life Sciences Recent Developments/Updates
Table 178. Meril Life Sciences Competitive Strengths & Weaknesses
Table 179. Tulip Diagnostics Basic Information, Manufacturing Base and Competitors
Table 180. Tulip Diagnostics Major Business
Table 181. Tulip Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 182. Tulip Diagnostics Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Tulip Diagnostics Recent Developments/Updates
Table 184. Tulip Diagnostics Competitive Strengths & Weaknesses
Table 185. Medical & Biological Laboratories Basic Information, Manufacturing Base and Competitors
Table 186. Medical & Biological Laboratories Major Business
Table 187. Medical & Biological Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 188. Medical & Biological Laboratories Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Medical & Biological Laboratories Recent Developments/Updates
Table 190. Medical & Biological Laboratories Competitive Strengths & Weaknesses
Table 191. GenBody Basic Information, Manufacturing Base and Competitors
Table 192. GenBody Major Business
Table 193. GenBody Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Product and Services
Table 194. GenBody Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. GenBody Recent Developments/Updates
Table 196. GenBody Competitive Strengths & Weaknesses
Table 197. Global Key Players of Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Upstream (Raw Materials)
Table 198. Global Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Typical Customers
LIST OF FIGURES
Figure 1. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Picture
Figure 2. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Total Revenue (2021-2032) & (USD Million)
Figure 4. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 13. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 16. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 18. China Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 23. India Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Markets in 2025
Figure 27. United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Type in 2025
Figure 31. Antigen Detection
Figure 32. Antibody Detection
Figure 33. Hormone Detection
Figure 34. Other
Figure 35. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Type (2021-2032)
Figure 36. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Output, (USD Million), 2021 & 2025 & 2032
Figure 37. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Assay Output in 2025
Figure 38. Qualitative Assays
Figure 39. Semi-quantitative Assays
Figure 40. Quantitative Assays
Figure 41. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Assay Output (2021-2032)
Figure 42. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Format, (USD Million), 2021 & 2025 & 2032
Figure 43. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Assay Format in 2025
Figure 44. Sandwich ELISA
Figure 45. Indirect ELISA
Figure 46. Other
Figure 47. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Assay Format (2021-2032)
Figure 48. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Application in 2025
Figure 50. Hospitals and Clinical Laboratories
Figure 51. Blood Centers and Plasma Screening Institutions
Figure 52. Independent Medical Laboratories
Figure 53. Other
Figure 54. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Application (2021-2032)
Figure 55. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Picture
Figure 2. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Total Revenue (2021-2032) & (USD Million)
Figure 4. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue (2021-2032) & (USD Million)
Figure 13. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 16. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 18. China Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 23. India Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Markets in 2025
Figure 27. United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Type in 2025
Figure 31. Antigen Detection
Figure 32. Antibody Detection
Figure 33. Hormone Detection
Figure 34. Other
Figure 35. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Type (2021-2032)
Figure 36. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Output, (USD Million), 2021 & 2025 & 2032
Figure 37. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Assay Output in 2025
Figure 38. Qualitative Assays
Figure 39. Semi-quantitative Assays
Figure 40. Quantitative Assays
Figure 41. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Assay Output (2021-2032)
Figure 42. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Assay Format, (USD Million), 2021 & 2025 & 2032
Figure 43. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Assay Format in 2025
Figure 44. Sandwich ELISA
Figure 45. Indirect ELISA
Figure 46. Other
Figure 47. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Assay Format (2021-2032)
Figure 48. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Application in 2025
Figure 50. Hospitals and Clinical Laboratories
Figure 51. Blood Centers and Plasma Screening Institutions
Figure 52. Independent Medical Laboratories
Figure 53. Other
Figure 54. World Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Market Size Market Share by Application (2021-2032)
Figure 55. Medical Enzyme-Linked Immunosorbent Assay (ELISA) Reagent Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
